オンコロジー臨床試験の世界市場に関する洞察、2028年までの予測Global Oncology Clinical Trial Market Insights, Forecast to 2028 臨床試験は、研究室での研究から始まる長いプロセスの最終段階です。 市場の分析と洞察オンコロジー臨床試験の世界市場 オンコロジー臨床試験の世界市場規模は、2021年の1億3660万米ドルから2028年には1億6840... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー臨床試験は、研究室での研究から始まる長いプロセスの最終段階です。市場の分析と洞察オンコロジー臨床試験の世界市場 オンコロジー臨床試験の世界市場規模は、2021年の1億3660万米ドルから2028年には1億6840万米ドルに達すると予測され、2022年から2028年の間に年平均成長率3.0%で推移するものと思われます。 オンコロジー臨床試験は、主にサロゲートエンドポイントを評価する初期段階の試験で、小規模、シングルアーム、オープンラベルであることが特徴です。 本レポートは、業界標準の分析精度と高いデータ整合性により、世界の腫瘍臨床試験市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するために役立つ素晴らしい試みを行っています。本レポートの購入者は、世界の腫瘍学的臨床試験市場の全体規模(収益ベース)を含む、検証済みで信頼できる市場予測にアクセスすることができます。 全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の腫瘍学的臨床試験市場における持続的な成功を確実にするために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界の腫瘍学臨床試験市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。 世界のオンコロジー臨床試験の範囲と市場規模 オンコロジー臨床試験市場は、プレイヤー別、地域(国)別、タイプ別、用途別に分類されます。世界の腫瘍学的臨床試験市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになります。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てます。 タイプ別セグメント 前立腺癌 肺がん 乳がん 白血病 その他 用途別セグメント 病院 クリニック 研究室 会社別 IQVIA チャールズリバー研究所 アイコン・プラットフォーム メデリス社 メドスペース・ホールディングス パレクセル・インターナショナル ファーマシューティカル・プロダクト・デベロプメント LLC ピボタル PRAヘルスサイエンス サイネオス・ヘルス 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア 北欧諸国 その他の欧州地域 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア ラテンアメリカ メキシコ ブラジル ラテンアメリカの残りの地域 中近東・アフリカ トルコ サウジアラビア UAE MEAの残りの地域 目次1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Prostate Cancer 1.2.3 Lung Cancer 1.2.4 Breast Cancer 1.2.5 Leukemia 1.2.6 Others 1.3 Market by Application 1.3.1 Global Oncology Clinical Trial Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Lab 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oncology Clinical Trial Market Perspective (2017-2028) 2.2 Oncology Clinical Trial Growth Trends by Region 2.2.1 Oncology Clinical Trial Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Oncology Clinical Trial Historic Market Size by Region (2017-2022) 2.2.3 Oncology Clinical Trial Forecasted Market Size by Region (2023-2028) 2.3 Oncology Clinical Trial Market Dynamics 2.3.1 Oncology Clinical Trial Industry Trends 2.3.2 Oncology Clinical Trial Market Drivers 2.3.3 Oncology Clinical Trial Market Challenges 2.3.4 Oncology Clinical Trial Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oncology Clinical Trial Players by Revenue 3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2017-2022) 3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2017-2022) 3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue 3.4 Global Oncology Clinical Trial Market Concentration Ratio 3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2021 3.5 Oncology Clinical Trial Key Players Head office and Area Served 3.6 Key Players Oncology Clinical Trial Product Solution and Service 3.7 Date of Enter into Oncology Clinical Trial Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Clinical Trial Breakdown Data by Type 4.1 Global Oncology Clinical Trial Historic Market Size by Type (2017-2022) 4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2023-2028) 5 Oncology Clinical Trial Breakdown Data by Application 5.1 Global Oncology Clinical Trial Historic Market Size by Application (2017-2022) 5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Oncology Clinical Trial Market Size (2017-2028) 6.2 North America Oncology Clinical Trial Market Size by Type 6.2.1 North America Oncology Clinical Trial Market Size by Type (2017-2022) 6.2.2 North America Oncology Clinical Trial Market Size by Type (2023-2028) 6.2.3 North America Oncology Clinical Trial Market Share by Type (2017-2028) 6.3 North America Oncology Clinical Trial Market Size by Application 6.3.1 North America Oncology Clinical Trial Market Size by Application (2017-2022) 6.3.2 North America Oncology Clinical Trial Market Size by Application (2023-2028) 6.3.3 North America Oncology Clinical Trial Market Share by Application (2017-2028) 6.4 North America Oncology Clinical Trial Market Size by Country 6.4.1 North America Oncology Clinical Trial Market Size by Country (2017-2022) 6.4.2 North America Oncology Clinical Trial Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Oncology Clinical Trial Market Size (2017-2028) 7.2 Europe Oncology Clinical Trial Market Size by Type 7.2.1 Europe Oncology Clinical Trial Market Size by Type (2017-2022) 7.2.2 Europe Oncology Clinical Trial Market Size by Type (2023-2028) 7.2.3 Europe Oncology Clinical Trial Market Share by Type (2017-2028) 7.3 Europe Oncology Clinical Trial Market Size by Application 7.3.1 Europe Oncology Clinical Trial Market Size by Application (2017-2022) 7.3.2 Europe Oncology Clinical Trial Market Size by Application (2023-2028) 7.3.3 Europe Oncology Clinical Trial Market Share by Application (2017-2028) 7.4 Europe Oncology Clinical Trial Market Size by Country 7.4.1 Europe Oncology Clinical Trial Market Size by Country (2017-2022) 7.4.2 Europe Oncology Clinical Trial Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Oncology Clinical Trial Market Size (2017-2028) 8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type 8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Oncology Clinical Trial Market Share by Type (2017-2028) 8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application 8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Oncology Clinical Trial Market Share by Application (2017-2028) 8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region 8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Oncology Clinical Trial Market Size (2017-2028) 9.2 Latin America Oncology Clinical Trial Market Size by Type 9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2017-2022) 9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2023-2028) 9.2.3 Latin America Oncology Clinical Trial Market Share by Type (2017-2028) 9.3 Latin America Oncology Clinical Trial Market Size by Application 9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2017-2022) 9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2023-2028) 9.3.3 Latin America Oncology Clinical Trial Market Share by Application (2017-2028) 9.4 Latin America Oncology Clinical Trial Market Size by Country 9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2017-2022) 9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oncology Clinical Trial Market Size (2017-2028) 10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type 10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Oncology Clinical Trial Market Share by Type (2017-2028) 10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application 10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Oncology Clinical Trial Market Share by Application (2017-2028) 10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country 10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 IQVIA 11.1.1 IQVIA Company Details 11.1.2 IQVIA Business Overview 11.1.3 IQVIA Oncology Clinical Trial Introduction 11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2017-2022) 11.1.5 IQVIA Recent Developments 11.2 Charles River Laboratory 11.2.1 Charles River Laboratory Company Details 11.2.2 Charles River Laboratory Business Overview 11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction 11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2017-2022) 11.2.5 Charles River Laboratory Recent Developments 11.3 ICON Plc 11.3.1 ICON Plc Company Details 11.3.2 ICON Plc Business Overview 11.3.3 ICON Plc Oncology Clinical Trial Introduction 11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2017-2022) 11.3.5 ICON Plc Recent Developments 11.4 Medelis, Inc. 11.4.1 Medelis, Inc. Company Details 11.4.2 Medelis, Inc. Business Overview 11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction 11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2017-2022) 11.4.5 Medelis, Inc. Recent Developments 11.5 Medpace Holdings, Inc. 11.5.1 Medpace Holdings, Inc. Company Details 11.5.2 Medpace Holdings, Inc. Business Overview 11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction 11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2017-2022) 11.5.5 Medpace Holdings, Inc. Recent Developments 11.6 PAREXEL International 11.6.1 PAREXEL International Company Details 11.6.2 PAREXEL International Business Overview 11.6.3 PAREXEL International Oncology Clinical Trial Introduction 11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2017-2022) 11.6.5 PAREXEL International Recent Developments 11.7 Pharmaceutical Product Development, LLC 11.7.1 Pharmaceutical Product Development, LLC Company Details 11.7.2 Pharmaceutical Product Development, LLC Business Overview 11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction 11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2017-2022) 11.7.5 Pharmaceutical Product Development, LLC Recent Developments 11.8 Pivotal 11.8.1 Pivotal Company Details 11.8.2 Pivotal Business Overview 11.8.3 Pivotal Oncology Clinical Trial Introduction 11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2017-2022) 11.8.5 Pivotal Recent Developments 11.9 PRA Health Sciences 11.9.1 PRA Health Sciences Company Details 11.9.2 PRA Health Sciences Business Overview 11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction 11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2017-2022) 11.9.5 PRA Health Sciences Recent Developments 11.10 Syneos Health 11.10.1 Syneos Health Company Details 11.10.2 Syneos Health Business Overview 11.10.3 Syneos Health Oncology Clinical Trial Introduction 11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2017-2022) 11.10.5 Syneos Health Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
SummaryClinical trials are the final step in a long process that begins with research in a lab. Table of Contents1 Report Business Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oncology Clinical Trial Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Prostate Cancer 1.2.3 Lung Cancer 1.2.4 Breast Cancer 1.2.5 Leukemia 1.2.6 Others 1.3 Market by Application 1.3.1 Global Oncology Clinical Trial Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Lab 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oncology Clinical Trial Market Perspective (2017-2028) 2.2 Oncology Clinical Trial Growth Trends by Region 2.2.1 Oncology Clinical Trial Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Oncology Clinical Trial Historic Market Size by Region (2017-2022) 2.2.3 Oncology Clinical Trial Forecasted Market Size by Region (2023-2028) 2.3 Oncology Clinical Trial Market Dynamics 2.3.1 Oncology Clinical Trial Industry Trends 2.3.2 Oncology Clinical Trial Market Drivers 2.3.3 Oncology Clinical Trial Market Challenges 2.3.4 Oncology Clinical Trial Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oncology Clinical Trial Players by Revenue 3.1.1 Global Top Oncology Clinical Trial Players by Revenue (2017-2022) 3.1.2 Global Oncology Clinical Trial Revenue Market Share by Players (2017-2022) 3.2 Global Oncology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Oncology Clinical Trial Revenue 3.4 Global Oncology Clinical Trial Market Concentration Ratio 3.4.1 Global Oncology Clinical Trial Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oncology Clinical Trial Revenue in 2021 3.5 Oncology Clinical Trial Key Players Head office and Area Served 3.6 Key Players Oncology Clinical Trial Product Solution and Service 3.7 Date of Enter into Oncology Clinical Trial Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Clinical Trial Breakdown Data by Type 4.1 Global Oncology Clinical Trial Historic Market Size by Type (2017-2022) 4.2 Global Oncology Clinical Trial Forecasted Market Size by Type (2023-2028) 5 Oncology Clinical Trial Breakdown Data by Application 5.1 Global Oncology Clinical Trial Historic Market Size by Application (2017-2022) 5.2 Global Oncology Clinical Trial Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Oncology Clinical Trial Market Size (2017-2028) 6.2 North America Oncology Clinical Trial Market Size by Type 6.2.1 North America Oncology Clinical Trial Market Size by Type (2017-2022) 6.2.2 North America Oncology Clinical Trial Market Size by Type (2023-2028) 6.2.3 North America Oncology Clinical Trial Market Share by Type (2017-2028) 6.3 North America Oncology Clinical Trial Market Size by Application 6.3.1 North America Oncology Clinical Trial Market Size by Application (2017-2022) 6.3.2 North America Oncology Clinical Trial Market Size by Application (2023-2028) 6.3.3 North America Oncology Clinical Trial Market Share by Application (2017-2028) 6.4 North America Oncology Clinical Trial Market Size by Country 6.4.1 North America Oncology Clinical Trial Market Size by Country (2017-2022) 6.4.2 North America Oncology Clinical Trial Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Oncology Clinical Trial Market Size (2017-2028) 7.2 Europe Oncology Clinical Trial Market Size by Type 7.2.1 Europe Oncology Clinical Trial Market Size by Type (2017-2022) 7.2.2 Europe Oncology Clinical Trial Market Size by Type (2023-2028) 7.2.3 Europe Oncology Clinical Trial Market Share by Type (2017-2028) 7.3 Europe Oncology Clinical Trial Market Size by Application 7.3.1 Europe Oncology Clinical Trial Market Size by Application (2017-2022) 7.3.2 Europe Oncology Clinical Trial Market Size by Application (2023-2028) 7.3.3 Europe Oncology Clinical Trial Market Share by Application (2017-2028) 7.4 Europe Oncology Clinical Trial Market Size by Country 7.4.1 Europe Oncology Clinical Trial Market Size by Country (2017-2022) 7.4.2 Europe Oncology Clinical Trial Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Oncology Clinical Trial Market Size (2017-2028) 8.2 Asia-Pacific Oncology Clinical Trial Market Size by Type 8.2.1 Asia-Pacific Oncology Clinical Trial Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Oncology Clinical Trial Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Oncology Clinical Trial Market Share by Type (2017-2028) 8.3 Asia-Pacific Oncology Clinical Trial Market Size by Application 8.3.1 Asia-Pacific Oncology Clinical Trial Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Oncology Clinical Trial Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Oncology Clinical Trial Market Share by Application (2017-2028) 8.4 Asia-Pacific Oncology Clinical Trial Market Size by Region 8.4.1 Asia-Pacific Oncology Clinical Trial Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Oncology Clinical Trial Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Oncology Clinical Trial Market Size (2017-2028) 9.2 Latin America Oncology Clinical Trial Market Size by Type 9.2.1 Latin America Oncology Clinical Trial Market Size by Type (2017-2022) 9.2.2 Latin America Oncology Clinical Trial Market Size by Type (2023-2028) 9.2.3 Latin America Oncology Clinical Trial Market Share by Type (2017-2028) 9.3 Latin America Oncology Clinical Trial Market Size by Application 9.3.1 Latin America Oncology Clinical Trial Market Size by Application (2017-2022) 9.3.2 Latin America Oncology Clinical Trial Market Size by Application (2023-2028) 9.3.3 Latin America Oncology Clinical Trial Market Share by Application (2017-2028) 9.4 Latin America Oncology Clinical Trial Market Size by Country 9.4.1 Latin America Oncology Clinical Trial Market Size by Country (2017-2022) 9.4.2 Latin America Oncology Clinical Trial Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oncology Clinical Trial Market Size (2017-2028) 10.2 Middle East & Africa Oncology Clinical Trial Market Size by Type 10.2.1 Middle East & Africa Oncology Clinical Trial Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Oncology Clinical Trial Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Oncology Clinical Trial Market Share by Type (2017-2028) 10.3 Middle East & Africa Oncology Clinical Trial Market Size by Application 10.3.1 Middle East & Africa Oncology Clinical Trial Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Oncology Clinical Trial Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Oncology Clinical Trial Market Share by Application (2017-2028) 10.4 Middle East & Africa Oncology Clinical Trial Market Size by Country 10.4.1 Middle East & Africa Oncology Clinical Trial Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Oncology Clinical Trial Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 IQVIA 11.1.1 IQVIA Company Details 11.1.2 IQVIA Business Overview 11.1.3 IQVIA Oncology Clinical Trial Introduction 11.1.4 IQVIA Revenue in Oncology Clinical Trial Business (2017-2022) 11.1.5 IQVIA Recent Developments 11.2 Charles River Laboratory 11.2.1 Charles River Laboratory Company Details 11.2.2 Charles River Laboratory Business Overview 11.2.3 Charles River Laboratory Oncology Clinical Trial Introduction 11.2.4 Charles River Laboratory Revenue in Oncology Clinical Trial Business (2017-2022) 11.2.5 Charles River Laboratory Recent Developments 11.3 ICON Plc 11.3.1 ICON Plc Company Details 11.3.2 ICON Plc Business Overview 11.3.3 ICON Plc Oncology Clinical Trial Introduction 11.3.4 ICON Plc Revenue in Oncology Clinical Trial Business (2017-2022) 11.3.5 ICON Plc Recent Developments 11.4 Medelis, Inc. 11.4.1 Medelis, Inc. Company Details 11.4.2 Medelis, Inc. Business Overview 11.4.3 Medelis, Inc. Oncology Clinical Trial Introduction 11.4.4 Medelis, Inc. Revenue in Oncology Clinical Trial Business (2017-2022) 11.4.5 Medelis, Inc. Recent Developments 11.5 Medpace Holdings, Inc. 11.5.1 Medpace Holdings, Inc. Company Details 11.5.2 Medpace Holdings, Inc. Business Overview 11.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Introduction 11.5.4 Medpace Holdings, Inc. Revenue in Oncology Clinical Trial Business (2017-2022) 11.5.5 Medpace Holdings, Inc. Recent Developments 11.6 PAREXEL International 11.6.1 PAREXEL International Company Details 11.6.2 PAREXEL International Business Overview 11.6.3 PAREXEL International Oncology Clinical Trial Introduction 11.6.4 PAREXEL International Revenue in Oncology Clinical Trial Business (2017-2022) 11.6.5 PAREXEL International Recent Developments 11.7 Pharmaceutical Product Development, LLC 11.7.1 Pharmaceutical Product Development, LLC Company Details 11.7.2 Pharmaceutical Product Development, LLC Business Overview 11.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Introduction 11.7.4 Pharmaceutical Product Development, LLC Revenue in Oncology Clinical Trial Business (2017-2022) 11.7.5 Pharmaceutical Product Development, LLC Recent Developments 11.8 Pivotal 11.8.1 Pivotal Company Details 11.8.2 Pivotal Business Overview 11.8.3 Pivotal Oncology Clinical Trial Introduction 11.8.4 Pivotal Revenue in Oncology Clinical Trial Business (2017-2022) 11.8.5 Pivotal Recent Developments 11.9 PRA Health Sciences 11.9.1 PRA Health Sciences Company Details 11.9.2 PRA Health Sciences Business Overview 11.9.3 PRA Health Sciences Oncology Clinical Trial Introduction 11.9.4 PRA Health Sciences Revenue in Oncology Clinical Trial Business (2017-2022) 11.9.5 PRA Health Sciences Recent Developments 11.10 Syneos Health 11.10.1 Syneos Health Company Details 11.10.2 Syneos Health Business Overview 11.10.3 Syneos Health Oncology Clinical Trial Introduction 11.10.4 Syneos Health Revenue in Oncology Clinical Trial Business (2017-2022) 11.10.5 Syneos Health Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(薬学的薬物)の最新刊レポートQYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(clinical trial)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |